サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1667694

肺気腫治療の世界市場：2025年

Emphysema Treatment Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
肺気腫治療の世界市場：2025年
出版日: 2025年02月28日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

肺気腫治療の市場規模は今後数年で急成長が見込まれます。CAGR 8.0％で推移し、2029年には74億米ドルに成長すると予測されています。

予測期間の成長は、人口の高齢化傾向、カスタマイズされた治療アプローチ、治療法へのアクセス拡大、症状管理の重視、ヘルスケアモデルの連携などに起因すると考えられています。予測期間の主な動向には、遺伝子治療の探求、患者教育とエンパワーメント、AIの統合、治療へのアクセス性の向上、長時間作用型薬剤の開発などがあります。

慢性閉塞性肺疾患 (COPD) の有病率の増加が今後の肺気腫治療市場の成長を促進すると予測されています。COPDには、肺気腫や慢性気管支炎など、気流の閉塞や呼吸困難を引き起こすさまざまな疾患が含まれます。肺気腫治療薬は、症状を緩和し、肺機能を回復させ、疾患の進行を遅らせることを目的としているため、COPDの進行を遅らせるために極めて重要です。Australian Institute of Health and Welfare (AIHW) の報告によると、2022年にはオーストラリアの人口の2.5％にあたる約63万8,000人がCOPDを罹患しています。2023年には、COPDは全疾患負担の3.6％を占め、呼吸器疾患に関連する全負担の50％を占めるようになっています。さらに、2022年にはCOPDが7,691人の死亡の根本原因となっており、これは人口10万人当たり29.6人の死亡に相当し、国内の全死亡の4.0％を占めています。これらのことから、COPD患者の増加が肺気腫治療市場の需要を牽引しています。

大気汚染の増加も今後数年間の肺気腫治療市場の成長を促進すると予測されています。粒子状物質や有毒ガスのレベルが上昇すると、肺気腫などの慢性閉塞性肺疾患 (COPD) を含む呼吸器疾患が悪化する可能性があります。大気汚染物質への曝露が増えると呼吸器疾患が急増し、肺気腫治療の需要が高まる可能性があります。例えば、米国環境保護庁 (EPA) の報告によると、2023年には米国で約6,600万トンの汚染物質が大気中に排出されています。

当レポートでは、世界の肺気腫治療の市場を調査し、市場概要・特徴、主要動向、市場影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 肺気腫治療市場：特徴

第3章 肺気腫治療市場：動向・戦略

第4章 肺気腫治療市場：マクロ経済シナリオ (金利、インフレ、地政学、COVID-19とその回復が市場に与える影響を含む)

第5章 世界の肺気腫治療市場：成長分析・戦略分析フレームワーク

  • PESTEL分析・成長推進因子/阻害因子
  • エンドユーザー産業の分析
  • 市場成長率の分析
  • 市場規模の推移・成長率
  • 市場規模の成長予測
  • TAM (Total Addressable Market) 市場

第6章 肺気腫治療市場：セグメンテーション

  • 市場規模の推移・予測：治療法別
  • 禁煙
  • 気管支拡張薬
  • ステロイド
  • ロイコトリエン修飾薬
  • 酸素補給
  • 抗生物質
  • 遺伝子治療
  • 手術移植
  • 市場規模の推移・予測：流通チャネル別
  • オンラインプロバイダー
  • ドラッグストア・薬局
  • 病院薬局
  • 市場規模の推移・予測：エンドユーザー別
  • クリニック
  • 外科センター
  • その他
  • 市場規模の推移・予測：禁煙のサブタイプ別
  • ニコチン置換療法 (NRT)
  • 処方薬
  • 行動療法プログラム
  • 市場規模の推移・予測：気管支拡張剤のサブタイプ別
  • 短時間作用型ベータ刺激薬 (SABA)
  • 長時間作用型ベータ刺激薬 (LABA)
  • 抗コリン薬
  • 市場規模の推移・予測：ステロイドのサブタイプ別
  • 吸入コルチコステロイド (ICS)
  • 経口コルチコステロイド
  • 複合吸入器
  • 市場規模の推移・予測：ロイコトリエン修飾薬のサブタイプ別
  • モンテルカスト
  • ザフィルルカスト
  • 市場規模の推移・予測：酸素補給のサブタイプ別
  • ポータブル酸素濃縮器
  • 連続フロー酸素システム
  • パルス投与酸素システム
  • 市場規模の推移・予測：抗生物質のサブタイプ別
  • マクロライド
  • フルオロキノロン
  • テトラサイクリン
  • 市場規模の推移・予測：遺伝子治療のサブタイプ別
  • 遺伝子置換療法
  • アンチセンスオリゴヌクレオチド
  • 市場規模の推移・予測：手術移植のサブタイプ別
  • 肺容量減少手術 (LVRS)
  • 肺移植
  • 市場規模の推移・予測：その他の治療のサブタイプ別
  • 呼吸リハビリテーションプログラム
  • 栄養サポート
  • 緩和ケア

第7章 肺気腫治療市場：地域・国別分析

  • 市場規模の推移・予測：地域別
  • 市場規模の推移・予測：国別

第8章 アジア太平洋の肺気腫治療市場

第9章 中国の肺気腫治療市場

第10章 インドの肺気腫治療市場

第11章 日本の肺気腫治療市場

第12章 オーストラリアの肺気腫治療市場

第13章 インドネシアの肺気腫治療市場

第14章 韓国の肺気腫治療市場

第15章 西欧の肺気腫治療市場

第16章 英国の肺気腫治療市場

第17章 ドイツの肺気腫治療市場

第18章 フランスの肺気腫治療市場

第19章 イタリアの肺気腫治療市場

第20章 スペインの肺気腫治療市場

第21章 東欧の肺気腫治療市場

第22章 ロシアの肺気腫治療市場

第23章 北米の肺気腫治療市場

第24章 米国の肺気腫治療市場

第25章 カナダの肺気腫治療市場

第26章 南米の肺気腫治療市場

第27章 ブラジルの肺気腫治療市場

第28章 中東の肺気腫治療市場

第29章 アフリカの肺気腫治療市場

第30章 肺気腫治療市場：競合情勢と企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • AstraZeneca PLC
    • Teva Pharmaceutical Industries Ltd.
    • Novartis AG
    • GlaxoSmithKline PLC
    • Hikma Pharmaceuticals PLC

第31章 肺気腫治療市場：その他の大手および革新的企業

  • Boehringer Ingelheim GmbH
  • Mylan N.V.
  • Pfizer Inc.
  • Orion Oyj
  • Verona Pharma PLC
  • Pulmonx Corporation
  • Emphasys Medical Inc.
  • Halozyme Therapeutics Inc.
  • Mariposa Health Limited
  • Uptake Technologies Inc.
  • Respinova Ltd
  • Gala Therapeutics Inc.
  • Pulmatrix Inc.
  • Broncus Medical Inc.
  • Holaira Inc.

第32章 世界の肺気腫治療市場：競合ベンチマーキングとダッシュボード

第33章 肺気腫治療市場：主要M&A

第34章 肺気腫治療市場：最近の動向

第35章 肺気腫治療市場：潜在性の高い国・セグメント・戦略

  • 最も新しい機会を提供する国
  • 最も新しい機会を提供するセグメント
  • 成長戦略

第36章 付録

目次
Product Code: r24105

Emphysema treatment refers to medication for chronic obstructive pulmonary disease (COPD), a condition that leads to damage in the air sacs of the lungs, resulting in difficulty breathing. Treatments for emphysema aim to manage symptoms and slow the progression of the disease.

The primary treatments for emphysema include smoking cessation, bronchodilators, steroids, leukotriene modifiers, supplemental oxygen, antibiotics, gene therapy, surgery transplant, and others. Smoking cessation involves the cessation of smoking to reduce the risk of cancer and other significant health issues. This process helps minimize cravings and withdrawal symptoms while preventing nicotine binding. These treatments are available through various distribution channels, including online providers, drug stores, retail pharmacies, and hospital pharmacies. They are utilized by various end-users such as clinics, surgical centers, and others.

The emphysema treatment market research report is one of a series of new reports from The Business Research Company that provides emphysema treatment market statistics, including emphysema treatment industry global market size, regional shares, competitors with an emphysema treatment market share, detailed emphysema treatment market segments, market trends and opportunities, and any further data you may need to thrive in the emphysema treatment industry. This emphysema treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The emphysema treatment market size has grown strongly in recent years. It will grow from$5.15 billion in 2024 to $5.43 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to the smoking epidemic impact, advancements in medications, pulmonary rehabilitation programs, improved diagnostic tools, awareness and education

The emphysema treatment market size is expected to see strong growth in the next few years. It will grow to $7.4 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to aging population trends, customized treatment approaches, expanded access to therapies, focus on symptom management, and collaborative healthcare models. Major trends in the forecast period include the exploration of gene therapies, patient education and empowerment, integration of artificial intelligence (AI), increased accessibility to treatment, and long-acting medications development.

The increasing prevalence of chronic obstructive pulmonary disease (COPD) is anticipated to drive the growth of the emphysema treatment market in the future. COPD encompasses a range of disorders that lead to airflow obstruction and breathing difficulties, including emphysema and chronic bronchitis. Emphysema therapies are crucial for slowing the progression of COPD, as they aim to alleviate symptoms, restore lung function, and delay disease advancement. For example, reports from the Australian Institute of Health and Welfare (AIHW), an Australian agency, indicate that in 2022, approximately 638,000 individuals, or 2.5% of Australia's population, were living with COPD. By 2023, COPD accounted for 3.6% of the overall disease burden, representing 50% of the total burden associated with respiratory conditions. Additionally, in 2022, COPD was the underlying cause of 7,691 deaths, which translates to 29.6 deaths per 100,000 people and constitutes 4.0% of all deaths in the country. Consequently, the rise in COPD cases is driving demand in the emphysema treatment market.

The rise in air pollution is projected to drive the growth of the emphysema treatment market in the coming years. Air pollution refers to the presence of harmful or undesirable substances in the air, which can negatively impact both the environment and human health. Increased levels of particulate matter and toxic gases can worsen respiratory conditions, including chronic obstructive pulmonary disease (COPD) such as emphysema. Higher exposure to air pollutants may lead to a surge in respiratory diseases, thereby increasing the demand for emphysema treatments. For instance, reports from the Environmental Protection Agency (EPA), a US federal agency, indicate that in 2023, around 66 million tons of pollutants were emitted into the atmosphere in the United States. As a result, the growing levels of air pollution are contributing to the expansion of the emphysema treatment market.

Prominent companies in the emphysema market are striving to gain a competitive advantage by developing minimally invasive procedures tailored for emphysema patients. Minimally invasive procedures involve medical interventions or surgical techniques that aim to cause minimal disruption to the body's normal structures. For example, in January 2022, Adena Health System, a healthcare company based in the United States, introduced Zephyr Valve surgery as a minimally invasive alternative to traditional lung volume reduction surgery for individuals experiencing lung hyperinflation, a common issue in emphysema and COPD. This innovative procedure involves the placement of small, one-way Zephyr Valves in the lungs' airways through a bronchoscope. These valves facilitate the release of trapped air, preventing further accumulation and enabling healthier lung areas to expand, thereby improving breathing.

Leading companies in the emphysema market are also focusing on the development of innovative products, such as inhalation aerosols, to establish a competitive edge. Inhalation aerosols are pharmaceutical formulations dispensed as a fine mist or spray of liquid medication suspended in a propellant or propellant mixture. For instance, in July 2023, Viatris Inc., a U.S.-based pharmaceutical company, in collaboration with Kindeva Drug Delivery L.P., a U.S.-based pharmaceutical contract development and manufacturing organization (CDMO), launched Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol. This marks the first FDA-approved generic version of AstraZeneca's Symbicort, catering to patients managing asthma, chronic obstructive pulmonary disease (COPD), and emphysema. Breyna, available in various dosage strengths, signifies a crucial advancement in providing accessible and cost-effective treatment options for individuals facing respiratory challenges.

In March 2023, UC Davis Health, an academic health institution based in the United States, entered into a collaboration with Propeller Health to offer individualized treatment for chronic obstructive pulmonary disease (COPD) and asthma through remote patient monitoring technology. This partnership allows UC Davis Health to provide eligible patients with Propeller Health's remote patient monitoring (RPM) service, delivering personalized therapy for high-risk COPD and asthma patients using sensors, a smartphone application, and a website. Propeller Health, a U.S.-based mobile platform company, provides sensors, mobile apps, analytics, and services to assist in respiratory health management.

Major companies operating in the emphysema treatment market include AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Halozyme Therapeutics Inc., Mariposa Health Limited, Uptake Technologies Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc., Olympus Corporation

North America was the largest region in the emphysema treatment market in 2024. The regions covered in the emphysema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the emphysema treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The emphysema treatment market includes revenues earned by entities by providing medical services such as bronchodilator medications, anti-inflammatory medication, oxygen therapy, lifestyle change consultation, and interventional therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Emphysema Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on emphysema treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for emphysema treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The emphysema treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Treatment: Smoking Cessation; Bronchodilators; Steroids; Leukotriene Modifiers; Supplemental Oxygen; Antibiotics; Gene Therapy; Surgery Transplant; Other Treatments
  • 2) By Distribution Channel: Online Providers; Drug Stores and Retail Pharmacies; Hospital Pharmacies
  • 3) By End-User: Clinics; Surgical Centre; Other End-Users
  • Subsegments:
  • 1) By Smoking Cessation: Nicotine Replacement Therapy (NRT); Prescription Medications; Behavioral Therapy Programs
  • 2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs); Long-Acting Beta-Agonists (LABAs); Anticholinergics
  • 3) By Steroids: Inhaled Corticosteroids (ICS); Oral Corticosteroids; Combination Inhalers
  • 4) By Leukotriene Modifiers: Montelukast; Zafirlukast
  • 5) By Supplemental Oxygen: Portable Oxygen Concentrators; Continuous Flow Oxygen Systems; Pulse Dose Oxygen Systems
  • 6) By Antibiotics: Macrolides; Fluoroquinolones; Tetracyclines
  • 7) By Gene Therapy: Gene Replacement Therapy; Antisense Oligonucleotides
  • 8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS); Lung Transplantation
  • 9) By Other Treatments: Pulmonary Rehabilitation Programs; Nutritional Support; Palliative Care
  • Companies Mentioned: AstraZeneca PLC; Teva Pharmaceutical Industries Ltd.; Novartis AG; GlaxoSmithKline PLC; Hikma Pharmaceuticals PLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Emphysema Treatment Market Characteristics

3. Emphysema Treatment Market Trends And Strategies

4. Emphysema Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Emphysema Treatment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Emphysema Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Emphysema Treatment Market Growth Rate Analysis
  • 5.4. Global Emphysema Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Emphysema Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Emphysema Treatment Total Addressable Market (TAM)

6. Emphysema Treatment Market Segmentation

  • 6.1. Global Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Smoking Cessation
  • Bronchodilators
  • Steroids
  • Leukotriene Modifiers
  • Supplemental Oxygen
  • Antibiotics
  • Gene Therapy
  • Surgery Transplant
  • 6.2. Global Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Online Providers
  • Drug Stores and Retail Pharmacies
  • Hospital Pharmacies
  • 6.3. Global Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinics
  • Surgical Centre
  • Other End-Users
  • 6.4. Global Emphysema Treatment Market, Sub-Segmentation Of Smoking Cessation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nicotine Replacement Therapy (NRT)
  • Prescription Medications
  • Behavioral Therapy Programs
  • 6.5. Global Emphysema Treatment Market, Sub-Segmentation Of Bronchodilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Short-Acting Beta-Agonists (SABAs)
  • Long-Acting Beta-Agonists (LABAs)
  • Anticholinergics
  • 6.6. Global Emphysema Treatment Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Inhaled Corticosteroids (ICS)
  • Oral Corticosteroids
  • Combination Inhalers
  • 6.7. Global Emphysema Treatment Market, Sub-Segmentation Of Leukotriene Modifiers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Montelukast
  • Zafirlukast
  • 6.8. Global Emphysema Treatment Market, Sub-Segmentation Of Supplemental Oxygen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Portable Oxygen Concentrators
  • Continuous Flow Oxygen Systems
  • Pulse Dose Oxygen Systems
  • 6.9. Global Emphysema Treatment Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Macrolides
  • Fluoroquinolones
  • Tetracyclines
  • 6.10. Global Emphysema Treatment Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gene Replacement Therapy
  • Antisense Oligonucleotides
  • 6.11. Global Emphysema Treatment Market, Sub-Segmentation Of Surgery Transplant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lung Volume Reduction Surgery (LVRS)
  • Lung Transplantation
  • 6.12. Global Emphysema Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pulmonary Rehabilitation Programs
  • Nutritional Support
  • Palliative Care

7. Emphysema Treatment Market Regional And Country Analysis

  • 7.1. Global Emphysema Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Emphysema Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Emphysema Treatment Market

  • 8.1. Asia-Pacific Emphysema Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Emphysema Treatment Market

  • 9.1. China Emphysema Treatment Market Overview
  • 9.2. China Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Emphysema Treatment Market

  • 10.1. India Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Emphysema Treatment Market

  • 11.1. Japan Emphysema Treatment Market Overview
  • 11.2. Japan Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Emphysema Treatment Market

  • 12.1. Australia Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Emphysema Treatment Market

  • 13.1. Indonesia Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Emphysema Treatment Market

  • 14.1. South Korea Emphysema Treatment Market Overview
  • 14.2. South Korea Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Emphysema Treatment Market

  • 15.1. Western Europe Emphysema Treatment Market Overview
  • 15.2. Western Europe Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Emphysema Treatment Market

  • 16.1. UK Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Emphysema Treatment Market

  • 17.1. Germany Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Emphysema Treatment Market

  • 18.1. France Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Emphysema Treatment Market

  • 19.1. Italy Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Emphysema Treatment Market

  • 20.1. Spain Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Emphysema Treatment Market

  • 21.1. Eastern Europe Emphysema Treatment Market Overview
  • 21.2. Eastern Europe Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Emphysema Treatment Market

  • 22.1. Russia Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Emphysema Treatment Market

  • 23.1. North America Emphysema Treatment Market Overview
  • 23.2. North America Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Emphysema Treatment Market

  • 24.1. USA Emphysema Treatment Market Overview
  • 24.2. USA Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Emphysema Treatment Market

  • 25.1. Canada Emphysema Treatment Market Overview
  • 25.2. Canada Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Emphysema Treatment Market

  • 26.1. South America Emphysema Treatment Market Overview
  • 26.2. South America Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Emphysema Treatment Market

  • 27.1. Brazil Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Emphysema Treatment Market

  • 28.1. Middle East Emphysema Treatment Market Overview
  • 28.2. Middle East Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Emphysema Treatment Market

  • 29.1. Africa Emphysema Treatment Market Overview
  • 29.2. Africa Emphysema Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Emphysema Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Emphysema Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Emphysema Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Emphysema Treatment Market Competitive Landscape
  • 30.2. Emphysema Treatment Market Company Profiles
    • 30.2.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Hikma Pharmaceuticals PLC Overview, Products and Services, Strategy and Financial Analysis

31. Emphysema Treatment Market Other Major And Innovative Companies

  • 31.1. Boehringer Ingelheim GmbH
  • 31.2. Mylan N.V.
  • 31.3. Pfizer Inc.
  • 31.4. Orion Oyj
  • 31.5. Verona Pharma PLC
  • 31.6. Pulmonx Corporation
  • 31.7. Emphasys Medical Inc.
  • 31.8. Halozyme Therapeutics Inc.
  • 31.9. Mariposa Health Limited
  • 31.10. Uptake Technologies Inc.
  • 31.11. Respinova Ltd
  • 31.12. Gala Therapeutics Inc.
  • 31.13. Pulmatrix Inc.
  • 31.14. Broncus Medical Inc.
  • 31.15. Holaira Inc.

32. Global Emphysema Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Emphysema Treatment Market

34. Recent Developments In The Emphysema Treatment Market

35. Emphysema Treatment Market High Potential Countries, Segments and Strategies

  • 35.1 Emphysema Treatment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Emphysema Treatment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Emphysema Treatment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer